Comparison of Pain of Two Different Methods in Uterine Artery Embolization
NCT ID: NCT03420248
Last Updated: 2019-09-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2018-04-19
2019-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Spherical Gelfoam Versus Tri-acryl Microsphere for Uterine Artery Embolization for Symptomatic Fibroids
NCT04960293
Intrauterine Device Versus Uterine Artery Embolization for Adenomyosis
NCT06043583
Hysteroscopic Cryomyolysis for the Treatment of Submucosal Leiomyomata
NCT00731341
Heparin Solution Versus Anti-adhesion Barrier Gel for Intrauterine Adhesions Prevention After Operative Hysteroscopy
NCT05257213
Vaginal Misoprostol Versus Bilateral Uterine Artery Ligation in Decreasing Blood Loss in Trans-abdominal Myomectomy
NCT02643186
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-spherical polyvinyl alcohol particle
For embolic material, non-spherical polyvinyl alcohol particle is used.
Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere
One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.
Tris-acryl gelatin microsphere
For embolic material, Tris-acryl gelatin microsphere is used.
Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere
One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-spherical polyvinyl alcohol particle or Tris-acryl gelatin microsphere
One of non-spherical polyvinyl alcohol particle or tris-acryl gelatin microsphere is used for embolic materials. All other processes are same.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Drug allergy
* Bradycardia (\<45 bpm) or heart block
* Uncontrolled hypertension
20 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Severance Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
So Yeon Kim
Assistant professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
So Yeon Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute, Severance Hospital, Yonsei University College of Medicine
Man Deuk Kim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sesverance Hospital, Yonsei University College of Medicine
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4-2016-1108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.